mRNA Cancer Therapies Patent Landscape 2022: Featuring BioNTech, Moderna, Novartis, Sanofi & Others
04 oct. 2022 04h03 HE | Research and Markets
Dublin, Oct. 04, 2022 (GLOBE NEWSWIRE) -- The "mRNA Cancer Therapies Patent Landscape 2022" report has been added to ResearchAndMarkets.com's offering. For nearly three decades, extensive efforts...
ImmunOs Therapeutics Announces Appointment of Joseph Leveque, MD, to its Board of Directors
04 oct. 2022 04h00 HE | AKAMPION
- Seasoned immuno-oncology executive brings significant medical and biopharma expertise Schlieren (Zurich Area), Switzerland, and Gaithersburg, MD, USA – October 4, 2022 – ImmunOs Therapeutics...
Sensei_Logo_RGB_Logo_Full-Color.png
Sensei Biotherapeutics Presents Preclinical Data for SNS-101, a Conditionally Active VISTA-blocking Antibody, at the Sixth Annual CRI-ENCI-AACR International Cancer Immunotherapy Conference: Translating Science into Survival
30 sept. 2022 16h05 HE | Sensei Biotherapeutics
- SNS-101 demonstrated a favorable pharmacokinetic profile, enhanced anti-tumor effects in combination with anti-PD-1 antibodies and a significantly improved cytokine release profile as compared to a...
22157.jpg
Global Immunotherapy Market Report 2022: Increasing Prevalence of Auto-Immune Diseases Driving Growth
28 sept. 2022 05h33 HE | Research and Markets
Dublin, Sept. 28, 2022 (GLOBE NEWSWIRE) -- The "Global Immunotherapy Market Research and Forecast, 2022-2028" report has been added to ResearchAndMarkets.com's offering. The global immunotherapy...
22157.jpg
Global PD-1/PDL-1 Inhibitor Market Report 2022: Increase in PD-1/PDL-1 Inhibitor Based Combination Regimens Fueling Sector
21 sept. 2022 07h53 HE | Research and Markets
Dublin, Sept. 21, 2022 (GLOBE NEWSWIRE) -- The "PD-1/PDL-1 Inhibitor Market - A Global and Regional Analysis: Focus on Epidemiology, Product, and Region - Analysis and Forecast, 2022-2032" report...
Global Head and Neck Cancer Therapeutics Market Report 2022: Advances in Biochemistry and Genomics Fuels Sector
16 sept. 2022 08h23 HE | Research and Markets
Dublin, Sept. 16, 2022 (GLOBE NEWSWIRE) -- The "Head and Neck Cancer Therapeutics: Global Markets" report has been added to ResearchAndMarkets.com's offering. This report aims to provide a...
22157.jpg
Cancer Immunotherapy Global Market Report 2022: Technologies Such as Immuno-Oncology, Cryoablation & Bone Marrow Transplant to Drive Growth
14 sept. 2022 05h43 HE | Research and Markets
Dublin, Sept. 14, 2022 (GLOBE NEWSWIRE) -- The "Cancer Immunotherapy Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering.The global cancer immunotheraphy market is...
Future Market Insights.png
Cancer Tissue Diagnostics Market is Expected to Grow at 6.6% CAGR over 2022-2032 | Future Market Insights, Inc. DUBAI, United Arab Emirates, Sept. 12, 2022 (GLOBE NEWSWIRE) -- The global cancer tissue diagnostics market is expected to reach a market valuation of US$ 5.3 Billion by the year 2022, accelerating...
logo.png
Enlivex Announces New Preclinical Data in Murine Mesothelioma Model Showing a Substantial Survival Benefit with Allocetra as Monotherapy and in Combination with Cisplatin at the ESMO Congress 2022
12 sept. 2022 08h00 HE | Enlivex Therapeutics Ltd
Currently used cisplatin-based combination treatments have limited efficacy against mesothelioma, which is one of the deadliest solid cancers Combining cisplatin with Allocetra™ led to a...
Lyell_Branding_Color_RGB_102918a copy.jpg
Lyell Immunopharma Presents First in Human Trial Design of LYL797 at ESMO 2022
12 sept. 2022 03h00 HE | Lyell Immunopharma, Inc
SOUTH SAN FRANCISCO, Calif., Sept. 12, 2022 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL), a clinical‑stage T-cell reprogramming company dedicated to developing curative cell therapies...